Tiêu Chí Phản Ứng Đã Được Sửa Đổi Cho U Lympho Ác Tính
Tóm tắt
Từ khóa
Tài liệu tham khảo
Pfistner B, Diehl V, Cheson B: International harmonization of trial parameters in malignant lymphoma. Eur J Haematol Suppl July:53,2005-54,
Jerusalem G, Beguin Y, Fassotte MF, et al: Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica 86:266,2001-273,
Hutchings M, Loft A, Hansen M, et al: Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 91:482,2006-489,
Querellou S, Valette F, Bodet-Milin C, et al: FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease. Ann Hematol 15:759,2006-767,
Gallamini A, Rigacci L, Merli F, et al: Predictive value of positron emission tomography performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. Haematologica 91:475,2006-481,
Juweid ME, Stroobants S, Hoekstra OS, et al: Use of positron emission tomography for response assessment of lymphoma: Consensus recommendations of the Imaging Subcommittee of the International Harmonization Project in Lymphoma. J Clin Oncol 10.1200/JCO.2006.08.2305
Lewis PJ, Salama A: Uptake of fluorine-18-flouorodeoxyglucose in sarcoidosis. J Nucl Med 35:1647,1994-1649,
Kostakoglu L, Coleman M, Leonard JP, et al: PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. J Nucl Med 43:1018,2002-1027,
Copie-Bergman C, Capella C, Motta T, et al: Validation of the GELA scoring system for evaluating gastric biopsies from patients with MALT lymphoma following eradication of . Ann Oncol 16:v94,2005, (suppl 5; abstr 194)Helicobacter pylori
Foltz LM, Song KW, Connors JM: Who actually detects relapse in Hodgkin lymphoma: Patient or physician. Blood 104 (part 1):853a,2004-854a, (abstr 3124)